| 4612 |
Centers for Disease Control and Prevention |
Html |
en |
Emergency Supplies for Earthquake Preparedness|Earthquakes |
Information on terrorism and public health. Provided by the Centers for Disease Control and Prevention (CDC). |
| survival kit | 0.974525 |
| tool box | 0.639039 |
| Important medical information | 0.841173 |
| emergency water | 0.633043 |
| aid supplies | 0.617105 |
| survival kits | 0.735996 |
| small bag | 0.636385 |
| aid kit | 0.626819 |
| earthquake | 0.462757 |
| emergency supplies | 0.643062 |
| home | 0.49258 |
|
| following supplies | 0.642698 |
| automobile | 0.525565 |
| fires | 0.458914 |
| excellent protection | 0.646913 |
| fishing tackle box | 0.853758 |
| supplies | 0.733341 |
| backpack | 0.460216 |
| following items | 0.654123 |
| Store enough supplies | 0.628321 |
| workplace | 0.521231 |
| refrigerator | 0.465821 |
|
CLICK HERE |
| 8361 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Screening Performance of Diabetes Risk Scores Among Asians and Whites in Rural Kerala, India - CDC |
We compared the screening performance of risk scores for Asians and whites for diabetes, dysglycemia, and metabolic syndrome. |
| study participants | 0.481752 |
| lipid abnormality | 0.620999 |
| outcome measures | 0.628271 |
| Rotterdam Prediction Model | 0.609973 |
| systolic blood pressure | 0.606924 |
| Diabetes Association questionnaire | 0.534543 |
| Diabetes Risk Assessment | 0.540891 |
| diastolic blood pressure | 0.606824 |
| Fasting plasma glucose | 0.58452 |
| Sree Chitra Tirunal | 0.614908 |
| World Diabetes Congress | 0.530983 |
| diabetes risk scores | 0.68227 |
| Indian Diabetes Risk | 0.541049 |
| blood pressure | 0.733912 |
| elevated blood glucose | 0.528996 |
| risk factors | 0.485805 |
| waist circumference | 0.528679 |
| body mass index | 0.619964 |
| negatives/true negatives | 0.551509 |
| previously diagnosed hypertension | 0.602311 |
| mm Hg | 0.585061 |
| diabetes risk | 0.698318 |
| metabolic syndrome | 0.837694 |
| Health Organization guidelines | 0.482339 |
| Finnish Diabetes Risk | 0.600287 |
|
| antidiabetes medication | 0.656763 |
| study | 0.521993 |
| Thiruvananthapuram district | 0.498559 |
| Chitra Tirunal Institute | 0.61286 |
| false negatives | 0.547623 |
| plasma glucose | 0.825491 |
| Medical Sciences | 0.513047 |
| mg/dL | 0.522177 |
| characteristic curves | 0.486234 |
| Diabetes Risk Score | 0.636611 |
| rural India | 0.57724 |
| International Diabetes Federation | 0.611318 |
| screening performance | 0.633972 |
| positives/true positives | 0.5562 |
| false positives | 0.5521 |
| physical activity | 0.519143 |
| HDL cholesterol | 0.518059 |
| confirmatory biochemical testing | 0.547298 |
| Diabetes Federation criteria | 0.546747 |
| Asian DRSs | 0.576203 |
| American Diabetes Association | 0.600037 |
| white diabetes risk | 0.586798 |
| antihypertensive medication | 0.491818 |
| diabetes | 0.749328 |
|
CLICK HERE |
| 8724 |
Centers for Disease Control and Prevention |
Html |
en |
CDC - Who is Most Likely to Get Ill from a RecreationalWater Illness RWI? - Recreational Water Illness RWI - HealthySwimming & Recreational Water - Healthy Water |
null |
|
|
CLICK HERE |
| 8970 |
Centers for Disease Control and Prevention |
Html |
en |
Do a SWOT Analysis - Evaluate a CoP - Resource Kit |
null |
| CoP | 0.936944 |
| critical factors | 0.429565 |
| achievement | 0.24328 |
| reside | 0.25121 |
| swot analysis | 0.913257 |
| Template | 0.242045 |
| external factors | 0.815759 |
| weaknesses | 0.407833 |
| members | 0.283685 |
| context | 0.244333 |
| CoP activities | 0.537602 |
| threats | 0.382448 |
| goals | 0.272559 |
|
| area | 0.245949 |
| needs | 0.242467 |
| internal positive attributes | 0.525482 |
| method | 0.246401 |
| CoP functions | 0.803022 |
| internal attributes | 0.372225 |
| resources | 0.242517 |
| opportunities | 0.29055 |
| picture | 0.242342 |
| environment | 0.242742 |
| Internal factors | 0.412987 |
| decision-making | 0.24636 |
| strengths | 0.400165 |
|
CLICK HERE |
| 10478 |
Centers for Disease Control and Prevention |
Html |
en |
Email Updates: May 7, 2012'Clinicians Outreach and Communication Activity (COCA) |
CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism. |
| Apr | 0.645009 |
| CDC | 0.946814 |
| Emergency Preparedness | 0.622115 |
| Flu Season Event | 0.628142 |
| Diamond Pet Foods | 0.678958 |
| community-wide disaster planning | 0.622295 |
| Chief Veterinary Officer | 0.67203 |
| – (CDC) | 0.725599 |
| Additional COCA Conference | 0.632829 |
| Plant Health Inspection | 0.6345 |
| Weekly Flu View | 0.629068 |
| U.S. Food | 0.62753 |
| USDA Chief Veterinary | 0.687054 |
| home health agencies | 0.932824 |
| Nature – Apr | 0.62342 |
| public health officials | 0.637159 |
| Blood Pressure Education | 0.703876 |
| disaster planning | 0.676037 |
| Flu – Apr | 0.634769 |
| nursing homes | 0.734546 |
| Salmonella Bareilly Infections | 0.659501 |
| United States | 0.659443 |
| COCA Email Update | 0.640806 |
| Salmonella serotype Bareilly | 0.662046 |
| public health community | 0.658991 |
|
| Veterinary Officer John | 0.677574 |
| preventable—public health problem | 0.632152 |
| Response funds Preparedness | 0.656834 |
| incorporate nursing homes | 0.626801 |
| CDC Respond | 0.733704 |
| flu vaccine promotion | 0.628477 |
| Eastern Daylight Time | 0.626426 |
| public health | 0.787417 |
| Specific Hazards preparedness | 0.632105 |
| FDA Unit Mobilizes | 0.651008 |
| Officer John Clifford | 0.6754 |
| Flu Prevention Partners | 0.633456 |
| CDC Scienceclips | 0.73825 |
| National High Blood | 0.703907 |
| Public Health Preparedness | 0.694856 |
| food safety | 0.622373 |
| FoodSafety.gov Reports FDA | 0.661286 |
| Salmonella Bareilly | 0.699003 |
| Diamond Puppy Formula | 0.669443 |
| high blood pressure | 0.81083 |
| us—have high blood | 0.624701 |
| USDA Food Recalls | 0.644443 |
| Response Training Resources | 0.627168 |
| public health research | 0.662298 |
|
CLICK HERE |
| 11618 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Smallpox | Smallpox Disease |
CDC overview of the smallpox vaccine. Includes basic information on the smallpox vaccine, its safety and availability, and who should not be vaccinated. Part of the CDC Emergency Preparedness & Response site. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 12095 |
Centers for Disease Control and Prevention |
Html |
en |
Provision of Antiretroviral Therapy for HIV-Positive TBPatients - 19 Countries, Sub-Saharan Africa, 2009-2013 |
E. Kainne Dokubo, MD1, Annabel Baddeley, MPH2, Ishani Pathmanathan, MD1, William Coggin, MSA3, Jacqueline Firth, MD4, Haileyesus Getahun, MD, PhD2, Jonathan Kaplan, MD1, Anand Date, MD1 (Author affiliations at end of text). |
| HIV-positive TB patients | 0.993452 |
| infectious TB disease | 0.293465 |
| ART | 0.296174 |
| new HIV-positive TB | 0.40346 |
| 2Global TB Programme | 0.270214 |
| TB disease | 0.42197 |
| TB contact history | 0.269707 |
| TB case detection | 0.268729 |
| TB diagnostic tests | 0.269256 |
| sub-Saharan Africa | 0.272867 |
| global TB | 0.294974 |
| new TB patients | 0.35788 |
| presumptive TB infection | 0.277375 |
| TB deaths | 0.262065 |
| timely TB treatment | 0.311856 |
| separate TB | 0.258853 |
| TB treatment | 0.424436 |
| HIV-positive new TB | 0.400179 |
|
| provider-initiated HIV testing | 0.210592 |
| TB surveillance systems | 0.265925 |
| TB cases | 0.301391 |
| TB disease detection | 0.284746 |
| global TB database* | 0.290716 |
| TB services | 0.273964 |
| ART coverage | 0.216213 |
| HIV-associated TB disease | 0.30838 |
| HIV care | 0.228118 |
| intensified TB | 0.278179 |
| TB diagnosis | 0.276582 |
| HIV testing | 0.22739 |
| high TB | 0.30474 |
| global TB control | 0.278506 |
| HIV infection | 0.266354 |
| TB symptoms | 0.256855 |
| TB case | 0.288823 |
|
CLICK HERE |
| 12126 |
Centers for Disease Control and Prevention |
Html |
en |
Transcript for CDC Telebriefing: New Vital Signs Report - How can increased HIV care and treatment prevent new infections and save lives? |
CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos. |
| treatment. Viral suppression | 0.47773 |
| viral suppression. | 0.49725 |
| HIV prevention | 0.579771 |
| jonathan mermin | 0.573588 |
| Dr. Mermin. | 0.521679 |
| biggest health impact | 0.4796 |
| new HIV | 0.611473 |
| viral suppression | 0.577835 |
| health care providers | 0.500925 |
| HIV aids prevention | 0.616414 |
| accessing health care | 0.49383 |
| national HIV response | 0.617602 |
| tom frieden | 0.726769 |
| national HIV AIDS | 0.614724 |
| HIV medical care | 0.6453 |
| health care system. | 0.492796 |
| HIV treatment | 0.602563 |
| HIV services | 0.565491 |
| Dr. Jonathan Mermin | 0.50214 |
| affordable care act | 0.526589 |
| Dr. | 0.55935 |
| HIV epidemic | 0.60266 |
| regular care | 0.477847 |
| HIV patient care | 0.666461 |
| Dr. Eugene McCray | 0.482167 |
|
| HIV infections. CDC | 0.625794 |
| critical health issues | 0.481216 |
| hiv aids | 0.661951 |
| HIV diagnosis | 0.589998 |
| Dr. Mermin | 0.535413 |
| health departments | 0.515938 |
| Dr. Tom Frieden | 0.544726 |
| health care | 0.59921 |
| health care systems | 0.510435 |
| Dr. Frieden. | 0.49469 |
| vital signs | 0.489917 |
| complex health care | 0.494708 |
| new HIV testing | 0.601733 |
| people | 0.723884 |
| HIV care | 0.7022 |
| HIV care… | 0.572424 |
| HIV screening | 0.564961 |
| HIV | 0.922456 |
| barbara reynolds | 0.675917 |
| HIV testing | 0.677178 |
| ongoing HIV care. | 0.634063 |
| HIV. Dr. Mermin | 0.495115 |
| Dr. Frieden | 0.550973 |
| HIV transmissions. | 0.584368 |
|
CLICK HERE |
| 13461 |
Centers for Disease Control and Prevention |
Html |
en |
Announcement: Additional Guidance Online for ProvidersRegarding 9-Valent HPV Vaccine Use Among Persons Who PreviouslyReceived HPV Vaccination |
A 9-valent human papillomavirus (HPV) vaccine (Gardasil 9, Merck and Co., Inc.) was licensed for use in females and males in the United States in December 2014 (1,2). |
| 9-valent HPV vaccine | 0.905676 |
| intraepithelial neoplasia | 0.300345 |
| endorsement | 0.243912 |
| United States | 0.296292 |
| original MMWR paper | 0.345009 |
| U.S. Government Printing | 0.341234 |
| Human Services | 0.355663 |
| Drug Administration | 0.295274 |
| HPV vaccine | 0.955432 |
| Iversen OE | 0.29921 |
| Engl J Med | 0.297374 |
| Merck | 0.21703 |
| U.S. Department | 0.355872 |
| MMWR HTML versions | 0.348334 |
| MMWR readers | 0.285422 |
| character translation | 0.278144 |
| Immunization Practices | 0.291669 |
| Advisory Committee | 0.289091 |
| Inc. | 0.215566 |
| quadrivalent HPV vaccine | 0.794975 |
| electronic PDF version | 0.341683 |
| Giuliano AR | 0.291754 |
| CDC website | 0.302618 |
| 9-valent human papillomavirus | 0.395799 |
|
| format errors | 0.279857 |
| Co. | 0.215574 |
| females | 0.293214 |
| Additional information | 0.286916 |
| Health | 0.226139 |
| Contact GPO | 0.297862 |
| typeset documents | 0.28328 |
| trade names | 0.282911 |
| commercial sources | 0.282845 |
| official text | 0.277038 |
| males | 0.270911 |
| routine vaccination | 0.365289 |
| bivalent HPV vaccine | 0.673693 |
| current prices | 0.278786 |
| ACIP recommendations | 0.313913 |
| non-CDC sites | 0.28156 |
| HPV vaccines | 0.514807 |
| original paper copy | 0.339166 |
| et al | 0.282452 |
| report | 0.227941 |
| Joura EA | 0.286551 |
| electronic conversions | 0.277162 |
| vaccine (http://www.cdc.gov/vaccines/who/teens/downloads/9vHPV-guidance.pdf). | 0.627483 |
|
CLICK HERE |
| 15400 |
Centers for Disease Control and Prevention |
Html |
en |
Understanding Barriers to Colorectal Cancer Screening inKentucky |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| Kentucky Behavioral Risk | 0.569775 |
| health insurance | 0.590687 |
| screening colonoscopy | 0.521429 |
| health care provider | 0.802466 |
| Risk Factor Surveillance | 0.654467 |
| BRFSS barriers | 0.50005 |
| high school education | 0.992611 |
| insurance coverage | 0.582544 |
| preventive screening | 0.517503 |
| Prev Med | 0.496863 |
| structural barriers | 0.505146 |
| CRC screening questions | 0.599799 |
| common barriers | 0.596585 |
| care systems barriers | 0.580743 |
| screening colonoscopies | 0.506164 |
| systems-level barriers | 0.504302 |
| colorectal cancer screening | 0.891056 |
| existing barriers | 0.514953 |
| health insurance coverage | 0.532636 |
| CRC screening | 0.946966 |
| CRC screening increases | 0.593546 |
| increase CRC | 0.496066 |
| Non-Hispanic black respondents | 0.486278 |
| Affordable Care Act | 0.488762 |
| respondents | 0.536554 |
|
| Behavioral Risk Factor | 0.653214 |
| cost barriers | 0.522756 |
| colonoscopy screening rates | 0.561899 |
| Kentucky CRC | 0.504396 |
| individual-level barriers | 0.505408 |
| cancer screening rates | 0.575282 |
| effective CRC screening | 0.601357 |
| multiple barriers | 0.51664 |
| increase screening | 0.506931 |
| greatest barriers | 0.527941 |
| public health | 0.504729 |
| health care systems | 0.548163 |
| colorectal cancer incidence | 0.487438 |
| patient-reported barriers | 0.516216 |
| specific barriers | 0.498308 |
| complex barriers | 0.497477 |
| CRC screening rates | 0.621026 |
| beliefs | 0.489847 |
| different screening methods | 0.52745 |
| white respondents | 0.504886 |
| regular health care | 0.510325 |
| barriers | 0.806945 |
| health insurance barriers | 0.540999 |
| New Mexico | 0.491141 |
|
CLICK HERE |